The Health IT Policy Committee (HITPC) adopted recommendations from its Consumer Empowerment Workgroup on patient-generated health data (PGHD) at its December meeting and is expected to finalize its complete Stage 3 recommendations in February.
The Health IT Policy Committee (HITPC) adopted recommendations from its Consumer Empowerment Workgroup on patient-generated health data (PGHD) at its December meeting and is expected to finalize its complete Stage 3 recommendations in February.
The committee reaffirmed that its objective--"patients [should] have the ability to electronically submit patient-generated health information"--should be part of Meaningful Use Stage 3, according to a report from a technical expert panel convened at the request of the Office of the National Coordinator.
This data, which could be submitted by a patient, caregiver or other designee, "could be an observation, a test result, a device finding, a confirmation or a change/correction/addition of data in the patient's existing health record"--data collected outside the clinical visit, explains a blog post at HealthITBuzz.
"As 2013 draws to a close, we are pleased to report that a lot of progress has made," writes Mary Jo Deering, senior policy advisor in the Office of Policy and Planning, of the ONC's efforts to better understand and implement policies concerning this data.
Read the full story here: http://bit.ly/19FezPe
Source: Fierce Health IT
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More